Montelukast added to fluticasone propionate does not alter inflammation or outcomes
Background Airway inflammation is a key pathological feature of asthma which underlies its clinical presentation. Objectives To examine whether adding a leukotriene modifier to an inhaled corticosteroid produces further clinical and/or anti-inflammatory benefits in patients symptomatic on short-a...
Main Authors: | , , , , , , , , , , , , , , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
2010-10.
|
Subjects: | |
Online Access: | Get fulltext |